GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » DSS Inc (AMEX:DSS) » Definitions » Change In Receivables

DSS (DSS) Change In Receivables : $0.24 Mil (TTM As of Mar. 2025)


View and export this data going back to 1995. Start your Free Trial

What is DSS Change In Receivables?

DSS's change in receivables for the quarter that ended in Mar. 2025 was $0.44 Mil. It means DSS's Accounts Receivable declined by $0.44 Mil from Dec. 2024 to Mar. 2025 .

DSS's change in receivables for the fiscal year that ended in Dec. 2024 was $1.14 Mil. It means DSS's Accounts Receivable declined by $1.14 Mil from Dec. 2023 to Dec. 2024 .

DSS's Accounts Receivable for the quarter that ended in Mar. 2025 was $2.63 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. DSS's Days Sales Outstanding for the three months ended in Mar. 2025 was 48.39.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. DSS's liquidation value for the three months ended in Mar. 2025 was $-48.56 Mil.


DSS Change In Receivables Historical Data

The historical data trend for DSS's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DSS Change In Receivables Chart

DSS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.67 -2.08 -1.72 1.32 1.14

DSS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.35 0.33 -0.12 -0.42 0.44

DSS Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DSS  (AMEX:DSS) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

DSS's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=2.627/4.954*91
=48.39

2. In Ben Graham's calculation of liquidation value, DSS's accounts receivable are only considered to be worth 75% of book value:

DSS's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=10.832-62.614+0.75 * 2.627+0.5 * 2.499
=-48.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DSS Change In Receivables Related Terms

Thank you for viewing the detailed overview of DSS's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


DSS Business Description

Traded in Other Exchanges
N/A
Address
275 Wiregrass Parkway, Henrietta, NY, USA, 14586
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.
Executives
Chan Heng Fai Ambrose director 2601 INSLAND PLACE TOWER, 510 KINGS RD N POINT, HONG KONG K3 999999999
Wu William Wai Leung director C/O DOCUMENT SECURITY SYSTEMS, INC., 200 CANAL VIEW BLVD., SUITE 300, ROCHESTER NY 14624
Lim Sheng Hon Danny director 4800 MONTGOMERY LANE, SUITE 210, BETHESDA MD 20814
Alset International Ltd 10 percent owner 10 WINSTEDT ROAD #02-02, SINGAPORE U0 227977
Hiu Pan Wong director RM F, 47/F, TOWER 6, PARK AVENUE,, 18 HOI TING ROAD, TAI KOK TUSI, KOWLOON, HONG KONG F4 999077
Shui Yeung Wong director 4800 MONTGOMERY LANE, SUITE 210, BETHESDA MD 20814
Todd D Macko officer: Interim CFO C/O 200 CANAL VIEW BLVD., SUITE 104, ROCHESTER NY 14623
Tung Moe Chan director 1601 BLAKE ST, SUITE 310, DENVER CO 80202
Global Biomedical Pte. Ltd. 10 percent owner 7 TEMASEK BOULEVARD #29-01B, SUNTEC TOWER ONE, SINGAPORE U0 038987
Sassuan (samson) Lee director 200 CANAL VIEW BLVD., SUITE 300, ROCHESTER NY 14623
Jose Escudero director 200 CANAL VIEW BOULEVARD, SUITE 300, ROCHESTER NY 14623
Jason Grady officer: Chief Operating Officer 1093 CARRINGTON WAY, VICTOR NY 14564
Joseph L. Sanders director C/O DOCUMENT SECURITY SYSTEMS, INC., 28 EAST MAIN STREET, SUITE 1525, ROCHESTER NY 14614
John Thatch director C/O SHARING SERVICES, INC., 1701 COIT ROAD, SUITE 100, PLANO TX 75075
Stanley V. Grisham director 2 CRESTED CLOUD CT., THE WOODLANDS TX 77380

DSS Headlines

From GuruFocus

Dillard's Inc: Fundamental Stock Research Analysis

By FAST Graphs FAST Graphs 12-07-2012